Skip to main content
Top
Published in: European Journal of Epidemiology 6/2018

01-06-2018 | CARDIOVASCULAR DISEASE

Hypothetical interventions to prevent stroke: an application of the parametric g-formula to a healthy middle-aged population

Authors: Anne M. Vangen-Lønne, Peter Ueda, Pablo Gulayin, Tom Wilsgaard, Ellisiv B. Mathiesen, Goodarz Danaei

Published in: European Journal of Epidemiology | Issue 6/2018

Login to get access

Abstract

The effects of interventions on multiple lifestyle and metabolic risk factors, initiated in midlife or later in a healthy population, on the long-term risk of first-ever stroke is not known. A particular methodological challenge in observational studies is to estimate the unbiased effect of a time-varying exposure in presence of time-varying confounders, if those confounders are affected by prior exposure. In such cases, the parametric g-formula can be applied to estimate an unbiased effect. We applied the parametric g-formula to estimate the 18-years (1994–2012) cumulative stroke risk under different scenarios of hypothetical interventions on levels of blood pressure, cholesterol, weight, physical activity, smoking and alcohol intake; and compared these to the observed scenario, to calculate the population risk ratios and risk differences. Among 14,796 eligible participants in the prospective, population-based Tromsø study (baseline mean age 46.1 years, 51% women), the observed 18-years stroke risk was 5.9%. A feasible joint hypothetical intervention on six lifestyle and metabolic risk factors would reduce the 18-year stroke risk by 32% (95% confidence interval 16, 44). A combination of more intensive interventions reduced the estimated 18-years stroke risk by 64% (95% confidence interval 40, 80). Blood pressure reduction and quitting smoking significantly reduced the risk when applied separately.
Appendix
Available only for authorised users
Literature
1.
go back to reference Feigin VL, Krishnamurthi RV, Parmar P, Norrving B, Mensah GA, Bennett DA, et al. Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990–2013: The GBD 2013 Study. Neuroepidemiology. 2015;45:161–76.CrossRefPubMedPubMedCentral Feigin VL, Krishnamurthi RV, Parmar P, Norrving B, Mensah GA, Bennett DA, et al. Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990–2013: The GBD 2013 Study. Neuroepidemiology. 2015;45:161–76.CrossRefPubMedPubMedCentral
2.
go back to reference Kissela BM, Khoury JC, Alwell K, Moomaw CJ, Woo D, Adeoye O, et al. Age at stroke: temporal trends in stroke incidence in a large, biracial population. Neurology. 2012;79:1781–7.CrossRefPubMedPubMedCentral Kissela BM, Khoury JC, Alwell K, Moomaw CJ, Woo D, Adeoye O, et al. Age at stroke: temporal trends in stroke incidence in a large, biracial population. Neurology. 2012;79:1781–7.CrossRefPubMedPubMedCentral
3.
go back to reference Benjamin EJ, Blaha MJ, Chiuve SE, et al. heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e46–603.CrossRef Benjamin EJ, Blaha MJ, Chiuve SE, et al. heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e46–603.CrossRef
4.
go back to reference Ezzati M, Hoorn SV, Rodgers A, Lopez AD, Mathers CD, Murray CJL, et al. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet. 2003;362:271–80.CrossRefPubMed Ezzati M, Hoorn SV, Rodgers A, Lopez AD, Mathers CD, Murray CJL, et al. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet. 2003;362:271–80.CrossRefPubMed
5.
go back to reference Neal B, MacMahon S, Chapman N, Blood Pressure Lowering Treatment Trialists’ Collaboration. Blood pressure lowering treatment trialists’ collaboration. effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists’ Collaboration. Lancet. 2000;356:1955–64.CrossRefPubMed Neal B, MacMahon S, Chapman N, Blood Pressure Lowering Treatment Trialists’ Collaboration. Blood pressure lowering treatment trialists’ collaboration. effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists’ Collaboration. Lancet. 2000;356:1955–64.CrossRefPubMed
6.
go back to reference Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–52.CrossRefPubMed Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–52.CrossRefPubMed
7.
go back to reference Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.CrossRefPubMed Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.CrossRefPubMed
8.
go back to reference Mihaylova B, Emberson J, Blackwell L, Keech A. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380:581–90.CrossRefPubMed Mihaylova B, Emberson J, Blackwell L, Keech A. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380:581–90.CrossRefPubMed
9.
go back to reference Estruch R, Ros E, Salas-Salvadó J, Covas M-I, Corella D, Arós F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368:1279–90.CrossRefPubMed Estruch R, Ros E, Salas-Salvadó J, Covas M-I, Corella D, Arós F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368:1279–90.CrossRefPubMed
10.
go back to reference Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women’s Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295:655–66.CrossRefPubMed Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women’s Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295:655–66.CrossRefPubMed
11.
go back to reference Chiuve SE, Rexrode KM, Spiegelman D, Logroscino G, Manson JE, Rimm EB. Primary prevention of stroke by healthy lifestyle. Circulation. 2008;118:947–54.CrossRefPubMedPubMedCentral Chiuve SE, Rexrode KM, Spiegelman D, Logroscino G, Manson JE, Rimm EB. Primary prevention of stroke by healthy lifestyle. Circulation. 2008;118:947–54.CrossRefPubMedPubMedCentral
12.
13.
go back to reference Zhang Y, Tuomilehto J, Jousilahti P, Wang Y, Antikainen R, Hu G. Lifestyle factors on the risks of ischemic and hemorrhagic stroke. Arch Intern Med. 2011;171:1811–8.CrossRefPubMed Zhang Y, Tuomilehto J, Jousilahti P, Wang Y, Antikainen R, Hu G. Lifestyle factors on the risks of ischemic and hemorrhagic stroke. Arch Intern Med. 2011;171:1811–8.CrossRefPubMed
14.
go back to reference Lawes CMM, Rodgers A, Bennett DA, Parag V, Suh I, Ueshima H, et al. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens. 2003;21:707–16.CrossRefPubMed Lawes CMM, Rodgers A, Bennett DA, Parag V, Suh I, Ueshima H, et al. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens. 2003;21:707–16.CrossRefPubMed
15.
go back to reference Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302:1993–2000.CrossRefPubMed Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302:1993–2000.CrossRefPubMed
16.
go back to reference Robins JM, Hernán MA. Estimation of the causal effects of time-varying exposures. In: Fitzmaurice G, Davidian M, Verbeke G, Molenberghs G, editors. Longitudinal data analysis. New York: Chapman and Hall/CRC Press; 2009. p. 553–99. Robins JM, Hernán MA. Estimation of the causal effects of time-varying exposures. In: Fitzmaurice G, Davidian M, Verbeke G, Molenberghs G, editors. Longitudinal data analysis. New York: Chapman and Hall/CRC Press; 2009. p. 553–99.
17.
go back to reference Robins J. A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect. Math Model. 1986;7:1393–512.CrossRef Robins J. A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect. Math Model. 1986;7:1393–512.CrossRef
18.
go back to reference Taubman SL, Robins JM, Mittleman MA, Hernán MA. Intervening on risk factors for coronary heart disease: an application of the parametric g-formula. Int J Epidemiol. 2009;38:1599–611.CrossRefPubMedPubMedCentral Taubman SL, Robins JM, Mittleman MA, Hernán MA. Intervening on risk factors for coronary heart disease: an application of the parametric g-formula. Int J Epidemiol. 2009;38:1599–611.CrossRefPubMedPubMedCentral
19.
go back to reference Mansournia MA, Etminan M, Danaei G, Kaufman JS, Collins G. Handling time-varying confounding in observational research. BMJ. 2017;359:j4587. Mansournia MA, Etminan M, Danaei G, Kaufman JS, Collins G. Handling time-varying confounding in observational research. BMJ. 2017;359:j4587.
20.
go back to reference Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njølstad I. Cohort profile: the Tromso Study. Int J Epidemiol. 2012;41:961–7.CrossRefPubMed Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njølstad I. Cohort profile: the Tromso Study. Int J Epidemiol. 2012;41:961–7.CrossRefPubMed
21.
go back to reference Eggen AE, Mathiesen EB, Wilsgaard T, Jacobsen BK, Njølstad I. The sixth survey of the Tromso Study (Tromso 6) in 2007–2008: collaborative research in the interface between clinical medicine and epidemiology: study objectives, design, data collection procedures, and attendance in a multipurpose population-based health survey. Scand J Public Health. 2013;41:65–80.CrossRefPubMed Eggen AE, Mathiesen EB, Wilsgaard T, Jacobsen BK, Njølstad I. The sixth survey of the Tromso Study (Tromso 6) in 2007–2008: collaborative research in the interface between clinical medicine and epidemiology: study objectives, design, data collection procedures, and attendance in a multipurpose population-based health survey. Scand J Public Health. 2013;41:65–80.CrossRefPubMed
22.
go back to reference The World Health Organization MONICA Project. (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol. 1988;41:105–14.CrossRef The World Health Organization MONICA Project. (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol. 1988;41:105–14.CrossRef
23.
go back to reference Nohlert E, Öhrvik J, Tegelberg Å, Tillgren P, Helgason ÁR. Long-term follow-up of a high- and a low-intensity smoking cessation intervention in a dental setting—a randomized trial. BMC Public Health. 2013;13:592.CrossRefPubMedPubMedCentral Nohlert E, Öhrvik J, Tegelberg Å, Tillgren P, Helgason ÁR. Long-term follow-up of a high- and a low-intensity smoking cessation intervention in a dental setting—a randomized trial. BMC Public Health. 2013;13:592.CrossRefPubMedPubMedCentral
24.
go back to reference Galanti MR, Ivarsson BH, Helgason AR, Gilljam H. Smoking cessation: gender on the agenda. Drugs Educ Prev Pol. 2002;1:71–84.CrossRef Galanti MR, Ivarsson BH, Helgason AR, Gilljam H. Smoking cessation: gender on the agenda. Drugs Educ Prev Pol. 2002;1:71–84.CrossRef
25.
go back to reference Raistrick D, Heather N, Godfrey C. Review of the Effectiveness of treatment for alcohol problems. National Treatment Agency for Substance Misuse. 2006. pp. 1–212. Raistrick D, Heather N, Godfrey C. Review of the Effectiveness of treatment for alcohol problems. National Treatment Agency for Substance Misuse. 2006. pp. 1–212.
26.
go back to reference Program National Cholesterol Education. Third report of the National Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Circulation. 2001;106:3143–421. Program National Cholesterol Education. Third report of the National Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Circulation. 2001;106:3143–421.
27.
go back to reference SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103–16.CrossRef SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103–16.CrossRef
28.
29.
go back to reference Garcia-Aymerich J, Varraso R, Danaei G, Camargo CA, Hernán MA. Incidence of adult-onset asthma after hypothetical interventions on body mass index and physical activity: an application of the parametric g-formula. Am J Epidemiol. 2014;179:20–6.CrossRefPubMed Garcia-Aymerich J, Varraso R, Danaei G, Camargo CA, Hernán MA. Incidence of adult-onset asthma after hypothetical interventions on body mass index and physical activity: an application of the parametric g-formula. Am J Epidemiol. 2014;179:20–6.CrossRefPubMed
30.
go back to reference Young JG, Cain LE, Robins JM, O’Reilly EJ, Hernán MA. Comparative effectiveness of dynamic treatment regimes: an application of the parametric g-formula. Stat Biosci. 2011;3:119–43.CrossRefPubMedPubMedCentral Young JG, Cain LE, Robins JM, O’Reilly EJ, Hernán MA. Comparative effectiveness of dynamic treatment regimes: an application of the parametric g-formula. Stat Biosci. 2011;3:119–43.CrossRefPubMedPubMedCentral
31.
go back to reference Ettehad D, Emdin CA, Kiran A, Anderson SG. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957–67.CrossRefPubMed Ettehad D, Emdin CA, Kiran A, Anderson SG. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957–67.CrossRefPubMed
32.
33.
go back to reference Shahar E, Chambless LE, Rosamond WD, Boland LL, Ballantyne CM, McGovern PG, et al. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2003;34:623–31.CrossRefPubMed Shahar E, Chambless LE, Rosamond WD, Boland LL, Ballantyne CM, McGovern PG, et al. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2003;34:623–31.CrossRefPubMed
34.
go back to reference Bots ML, Elwood PC, Nikitin Y, Salonen JT, de Concalves AF, Inzitari D, et al. Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health. 2002;56:i19–24.CrossRefPubMedPubMedCentral Bots ML, Elwood PC, Nikitin Y, Salonen JT, de Concalves AF, Inzitari D, et al. Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health. 2002;56:i19–24.CrossRefPubMedPubMedCentral
35.
go back to reference Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:3754–832.CrossRefPubMedPubMedCentral Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:3754–832.CrossRefPubMedPubMedCentral
36.
go back to reference Peters SAE, Huxley RR, Woodward M. Smoking as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 81 cohorts, including 3,980,359 individuals and 42,401 strokes. Stroke. 2013;44:2821–8.CrossRefPubMed Peters SAE, Huxley RR, Woodward M. Smoking as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 81 cohorts, including 3,980,359 individuals and 42,401 strokes. Stroke. 2013;44:2821–8.CrossRefPubMed
38.
go back to reference Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Rosner B, et al. Smoking cessation and decreased risk of stroke in women. JAMA. 1993;269:232–6.CrossRefPubMed Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Rosner B, et al. Smoking cessation and decreased risk of stroke in women. JAMA. 1993;269:232–6.CrossRefPubMed
39.
go back to reference Reynolds K, Lewis B, Nolen J, Kinney GL. Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003;289:579–88.CrossRefPubMed Reynolds K, Lewis B, Nolen J, Kinney GL. Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003;289:579–88.CrossRefPubMed
40.
go back to reference Larsson SC, Wallin A, Wolk A, Markus HS. Differing association of alcohol consumption with different stroke types: a systematic review and meta-analysis. BMC Med. 2016;14:178.CrossRefPubMedPubMedCentral Larsson SC, Wallin A, Wolk A, Markus HS. Differing association of alcohol consumption with different stroke types: a systematic review and meta-analysis. BMC Med. 2016;14:178.CrossRefPubMedPubMedCentral
41.
go back to reference Wannamethee SG, Shaper AG. Patterns of alcohol intake and risk of stroke in middle-aged British men. Stroke. 1996;27:1033–9.CrossRefPubMed Wannamethee SG, Shaper AG. Patterns of alcohol intake and risk of stroke in middle-aged British men. Stroke. 1996;27:1033–9.CrossRefPubMed
42.
go back to reference Hillbom M, Numminen H, Juvela S. Recent heavy drinking of alcohol and embolic stroke. Stroke. 1999;30:2307–12.CrossRefPubMed Hillbom M, Numminen H, Juvela S. Recent heavy drinking of alcohol and embolic stroke. Stroke. 1999;30:2307–12.CrossRefPubMed
43.
go back to reference Anderson P, Chisholm D, Fuhr DC. Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet. 2009;373:2234–46.CrossRefPubMed Anderson P, Chisholm D, Fuhr DC. Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet. 2009;373:2234–46.CrossRefPubMed
44.
go back to reference Bye EK, Amundsen EJ, Lund M. Bruk av tobakk, rusmidler og vanedannende legemidler i Norge-hovedfunn fra SIRUS’befolkningsundersøkelse i 2012. Statens Institutt for rusmiddelforskning (SIRUS). Statistikkrapport 6/2013. Bye EK, Amundsen EJ, Lund M. Bruk av tobakk, rusmidler og vanedannende legemidler i Norge-hovedfunn fra SIRUS’befolkningsundersøkelse i 2012. Statens Institutt for rusmiddelforskning (SIRUS). Statistikkrapport 6/2013.
45.
go back to reference Taubman S, Hernan MA. Does obesity shorten life? The importance of well-defined interventions to answer causal questions. Int J Obes. 2008;32(suppl 3):S8–14. Taubman S, Hernan MA. Does obesity shorten life? The importance of well-defined interventions to answer causal questions. Int J Obes. 2008;32(suppl 3):S8–14.
Metadata
Title
Hypothetical interventions to prevent stroke: an application of the parametric g-formula to a healthy middle-aged population
Authors
Anne M. Vangen-Lønne
Peter Ueda
Pablo Gulayin
Tom Wilsgaard
Ellisiv B. Mathiesen
Goodarz Danaei
Publication date
01-06-2018
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 6/2018
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-017-0344-x

Other articles of this Issue 6/2018

European Journal of Epidemiology 6/2018 Go to the issue